Not every possible human who has the illness will buy the drug. I think we need to be realistic with our royalties estimates. It will take years to build up a large patient base, and even then will never hit 100% saturation.
Your argument is like giving Xero a valuation of a trilllion $ because every human on earth might need to do taxes.
Ann: Neuren Corporate Presentation, October 2019, page-80
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.70 |
Change
-0.050(0.36%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $4.297M | 313.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 1148 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.71 | 741 | 15 |
View Market Depth
| Last trade - 14.43pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |